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Introduction
The use of antiretroviral therapy (ART)
has been shown to have significantly
improved morbidity; mortality and
prognosis of AIDS related conditions.1
HIV/AIDS has become a chronic
manageable condition in the developed
world yet in most parts of the developing
world HIV patients do not have access
to antiretroviral therapy.2
There is evidence, mainly from the
Western Cape and Gauteng, that ART
can work at the PHC level, however
there is no literature about it from less
resourced provinces like Limpopo. Bela
Bela is a sunshine town 100 km north
of Pretoria, with a population of 63000
inhabitants. The Bela Bela HIV
Prevention Group which was formed in
1996 by community members who are
concerned about HIV has performed
17740 tests in the area from 1997 to
February 2005 of which 7780 were
found to be positive. The antenatal
survey coordinated by the National
Department of Health in the year 2004
found that the HIV seroprevalence for
the Waterberg district in which Bela
Bela is situated is 26.6 % while Limpopo
province’s average is 19.3 %.3
This paper covers issues related to
achievements and chal lenges
encountered during the first six months
of an antiretroviral (ART) roll-out by the
HIV/AIDS Prevention Group at the
Primary Health Care level in Bela Bela,
Limpopo Province.
Interim Results
The HIV Prevention Group was selected
by the South African Catholic Bishop’s
Conference (SACBC) to be one of the
sites in the country where ART will be
rolled-out with the United States
President’s Emergency Plan For AIDS
Relief (PEPFAR) funding. The first phase
of the ART roll-out was from September
2004 to the end of February 2005.
The wellness clinic was established
a year after an exposure visit to MSF
Kayelitsha and Masipumelela projects
in the Western Cape. ART was
implemented at the Bela Bela
community clinic under the HIV
Prevention Group. A family physician,
part-time professional nurses, lay-
counsellors who are mainly people living
with HIV and a project administrator
worked on the project. Drugs and the
laboratory tests were funded with
support from PEPFAR. Drugs for
t rea tment  and preven t ion  o f
opportunistic infections were supplied
by the local State clinic.
The local clinic, hospital and private
practices referred patients on a booking
system two 2 days per week. Criteria
for inclusion included a CD4 count <200
(in adults) or < 15 % (in children) and/or
a stage IV WHO HIV disease.
S t a n d a rd i z e d  A RT  re g i m e n s
recommended by the national ART roll-
out for South Africa were adhered to.
Patients received stavudine, lamivudine
and efavirenz. Some female clients
received nevirapine as well as children
who did not receive nevirapine at birth.
Stavudine was replaced with zidovudine
in some patients. Medicines were
supplied by Motswedi pharmaceuticals
with patient’s name labeled. Blood tests
were done by TOGA laboratory in
Kempton Park. Nutritional support was
also provided.
Patients received a full physical
examination at the first consultation;
blood was drawn for FBC, VL and CD4
count as baseline. These tests were
repeated at six weeks post-ARV, twelve
weeks and 24 weeks after the doctor’s
consultation. Those qualifying for ART
are referred to a lay counsellor for ARVs
adherence counsel l ing.  Upon
successful  complet ion of ARV
adherence counseling, a home visit is
conducted before the application is
presented to the selection committee.
Patients who could not undergo the
ARV adherence counseling had a family
member do it for them. They will undergo
adherence counseling later when their
condition improves. All patients were
encouraged to bring a treatment partner
whom they live with and to whom they
will disclose their HIV status.
As a result of the delivery of ART,
se rv ice  u t i l i za t i on  i nc reased
tremendously. 335 patients registered
in order to be treated: of whom 221
were female and 114 were male. Sixty
five patients (21 males and 44 females)
started ART after successfully going
through ARV adherence counseling. Of
all the males 16 adults and 3 children
are doing well on ART; unfortunately 1
adult and 1 child died while on
treatment. Of all the females 39 adults
and 3 children are doing well on ART;
however 2 female adults died while on
ART.
The mean CD4 on starting ART was
79 for the first 13 patients: their mean
weight was 51.7 kg while the mean viral
load was 102449. After six weeks the
mean weight was 53.96 kg, the mean
viral load was 100, and the mean CD4
count was 198. Records for seven of
the first patients show that their mean
viral load went below 50 after 12 weeks
of treatment, the mean weight was 58.78
kg and the mean CD4 was 222.  For
the only patient that has undergone the
monitoring test at 24 weeks, the CD4
count started at 136, however at 24
weeks CD4 count was 690, viral
load<50 and a weight of 67 kg (Table
1).
Using a sample of first 20 patients,
the most common side-effects were
tiredness (40 % of patients), nausea
and vomiting (40 % of patients),
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headache (35 %), rash (25 % of
patients), diarrhea (25 % of patients),
dizziness (15 % of patients) and change
in appetite (15 % of patients). It is worth
noting that 20 % of patients did not
report any side-effects.
After 6 months of running the
program, there are 69 persons eligible
for ART. 40 of them are actively going
through ART adherence counseling, 10
are ready to start ART but have not yet
decided, 11 stopped half-way (through
the ART adherence counseling) and 8
have not done anything yet about
enter ing the ART programme.
Interestingly, the number of male
patients seeking help is increasing
unlike in the past. Compliance with
Doctor’s appointment has improved
enormously as the programme has
rolled-out: currently it is 90 %. Every
patient has managed to disclose their
HIV status to a person living with them
who has then supported them. It is very
interesting to find that there are a few
children who are effectively supporting
their parents. The filing system has been
excellent, no missing files are reported.
Continuity of care has been effective
and efficient.
The community of Bela Bela has
responded very well to the ART roll-out:
there is a high intake for VCT, there is
increased enthusiasm since some
patients have been seen to be doing
well, family members feel they can do
something for those infected and
affected by HIV, and project staff
members are warmly welcomed during
home visits. Some of the challenges
encountered include: TB diagnosis,
limited physical space, delays in
obtaining histology results, the loss of
State clinic cards hence patients come
to us without their medical history,
increasing and high patient’s loads.
Discussion
The project attracted several patients
hence 335 persons registered. There
were 2/3 females and 1/3 males. This
is consistent with health care utilization
patterns.
The deaths that occurred during
ART were related to HIV itself, not side-
effects of medicines. Nobody was
excluded from starting ART on grounds
of very low CD4 count hence the mean
CD4 was 79 for the first 13 patients
while the mean viral load was 102449
but dropped to 100 after six weeks of
treatment. This can be considered as
a huge success. Linda-Gail Bekker et
al reported that their first 16 patients
who received ART had a viral load<400
copies/ml after sixteen weeks of
treatment.4 Patients also received food
supplements from the State clinic hence
the mean weight increased.
Side effects were monitored using
a tool designed by Peter Adams.5 This
tool has most side-effects with numbers.
A patient has to record a record relevant
to the side-effect they experience on
daily basis at the time that they are
recording intake of the medicines. The
tool is available in English, Afrikaans
and African languages. The doctor went
through the sheet with the patient during
post-ART follow up consultation.
The national guidelines on use of
antiretrovirals states that ART may not
be given as an emergency treatment.6
Patients need to be ready before they
are put on ART. So there were 69
persons eligible for ART who did not
yet start ART. The increase of male
patients may be viewed as a sign that
the programme’s effectiveness has
spread through the word of mouth. The
high level of compliance with medical
doctor’s appointment is a sign of high
patient’s satisfaction.7, 8 The filing system
was critical in achieving the main
objectives of the ART roll-out. Fehrsen
recommends that chronic care need to
be shared and well organized in terms
of records.9 Various problems orientated
medical record tools were used to
capture patients’ visits in an organized,
user-friendly manner which allows easy
review or extraction of important data.
Conclusion
ART roll-out may be done smoothly at
primary health care level even in a
resource limited setting. It is more
convenient for patents and for staff. The
continuity of care supported by effective
patient records and filing system is
much desired. Networking with well-
functioning projects is essential.
Community involvement and support
by the local clinic and local hospital
were also remarkable. The public/private
partnership has been fruitful. Lay-
counsellors (who are mainly PWA’s) and
their facilitator (trainer) have played a
crit ical role in performing ART
adherence counselling as well as home
visits. However, the physical space
(wellness clinic), number of staff, budget
and working hours need to be reviewed.
Establishment of support care groups
for patients on ART is high on the priority
list for the next phase of the project.
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